Polarized electric field system for whole-body Covid-19 therapy
US11202673B1 · kind B1 · utility
Inventors
Key dates
| Filing date | Apr 28, 2021 |
| Grant date | Dec 21, 2021 |
| Priority date | — |
| Expiry date | Apr 28, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2202/14
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A non-invasive electrodynamic radiative electroporation system and method for safe in vivo delivery of specific radiant energy to physiologically inaccessible sites for selective destruction of biomolecular function of virions, particularly Covid-19 and its variants. The system and method applies a computer or like controller to generate, modulate, direct and deliver applied external electric fields from plural antennas to target tissues in the full respiratory tract, including lung microstructures, cardiovascular tissues and neuron networks. Electric fields exceeding a critical threshold-value interact with the virus lipid bilayer membranes, intra-membrane organelles, mRNA, and biomolecular scaffold assemblies, to destroy virion function through irreversible electroporation and electropermeabilization. Polarized electric fields are generated to provide force vectors in optimal dynamic angular distribution to the virion membrane surface and modulated within time-scales short compared to thermal transport characteristic times to effect the electroporation as an adiabatic process that preempts Joule heating of normal tissues.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.